Mechanism of renal excretion of AM-715, a new quinolonecarboxylic acid derivative, in rabbits, dogs, and humans.
The mechanisms of the renal excretion of AM-715, a synthetic antimicrobial agent, were studied in rabbits, dogs, and humans. In both rabbits and humans, AM-715 clearance was greater than creatinine clearance and was profoundly decreased by the administration of probenecid. Thus, in these subjects, AM 715 was cleared by both tubular secretion and glomerular filtration. In dogs, however, the excretion ratio (close to unity), biological half-life, and stop-flow pattern of AM-715 were not affected by probenecid, indicating that the renal excretion of AM-715 took place mostly through glomerular filtration. These results suggest that renal excretion of AM-715 differs with animal species.
D000328:Adult; D000818:Animals; D000890:Anti-Infective Agents / Q000378:metabolism*; D003404:Creatinine / Q000378:metabolism; D004285:Dogs; D006801:Humans; D007668:Kidney / Q000378:metabolism*; D008297:Male; D008657:Metabolic Clearance Rate / Q000187:drug effects; D009268:Nalidixic Acid / Q000031:analogs & derivatives* / Q000378:metabolism; D009643:Norfloxacin; D011339:Probenecid / Q000494:pharmacology*; D011817:Rabbits; D013045:Species Specificity
D000890:Anti-Infective Agents; D009268:Nalidixic Acid; D003404:Creatinine; D009643:Norfloxacin; D011339:Probenecid